Prediction of 6 months left ventricular dilatation after myocardial infarction in relation to cardiac morbidity and mortality: Application of a new dilatation model to GISSI-3 data

European Heart Journal

Volumn 23, Issue 7, 2002, Pages 536-542

  De Kam, P J ^a   Nicolosi, G L ^b   Voors, A A ^c   Van Den Berg, M P ^a   Brouwer, J ^a   Van Veldhuisen, D J ^a   Barlera, S ^d   Maggioni, A P ^e   Giannuzzi, P ^f   Temporelli, P L ^f   Latini, R ^d   Van Gilst, W H ^g  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b S MARIA DEGLI ANGELI HOSPITAL   (Italy)

^c ST ANTONIUS HOSPITAL   (Netherlands)

^d MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^e ANMCO RESEARCH CENTER   (Italy)

^f IRCCS   (Italy)

^g UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

2 D echocardiography; Cardiac morbidity; Left ventricular dilatation; Mortality; Myocardial infarction; Prediction model

Indexed keywords

ADULT; AGED; ANGINA PECTORIS; ARTICLE; FEMALE; HEART DILATATION; HEART INFARCTION; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE VOLUME; HEART REINFARCTION; HIGH RISK PATIENT; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MODEL; MORBIDITY; MORTALITY; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

DILATATION, PATHOLOGIC; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; VENTRICULAR REMODELING;

EID: 0036554934     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2001.2820     Document Type: Article

References (30)

1. Kannel WB, Sorlie P, McNamara PM. Prognosis after initial myocardial infarction: The Framingham study. Am J Cardiol 1979; 44: 53-9.
2. Moss AJ, Benhorin J. Prognosis and management after a first myocardial infarction. N Engl J Med 1990; 322: 743-53.
3. Dwyer EMJ, McMaster P, Greenberg H. Non fatal cardiac events and recurrent infarction in the year after acute myocardial infarction. J Am Coll Cardiol 1984; 4: 695-702.
4. White HD, Norris RM, Brown MA, Brandt PW, Whitlock RM, Wild CJ. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987; 76: 44-51.
5. Sharpe N, Murphy J, Smith H, Hannan S. Preventive treatment of asymptomatic left ventricular dysfunction following myocardial infarction. Eur Heart J 1990; 11 (Suppl B): 147-56.
6. Pfeffer JM, Lamas GA. Development and prevention of congestive heart failure following myocardial infarction. Circulation 1993; 87: IV120-IV125.
7. de Kam PJ, Voors AA, van den Berg MP et al. Effect of very early angiotensin-converting enzyme inhibition on left ventricular dilation after myocardial infarction in patients receiving thrombolysis: Results of a meta-analysis of 845 patients. FAMIS, CAPTIN and CATS Investigators. J Am Coll Cardiol 2000; 36: 2047-53.
8. GISSI-3-Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. GISSI-3 study protocol on the effects of lisinopril, of nitrates, and of their association in patients with acute myocardial infarction. Am J Cardiol 1992; 70: 62C-9C.
9. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. GISSI-3: Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 1994; 343: 1115-22.
10. Nicolosi GL, Latini R, Marino P et al. The prognostic value of predischarge quantitative two-dimensional echocardiographic measurements and the effects of early lisinopril treatment on left ventricular structure and function after acute myocardial infarction in the GISSI-3 Trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. Eur Heart J 1996; 17: 1646-56.
11. van Gilst WH, Kingma JH, Peels KH, Dambrink JH, St John Sutton M. Which patient benefits from early angiotensinconverting enzyme inhibition after myocardial infarction? Results of one-year serial echocardiographic follow-up from the Captopril and Thrombolysis Study (CATS). J Am Coll Cardiol 1996; 28: 114-21.
12. Hutchins GM, Bulkley BH. Infarct expansion versus extension: Two different complications of acute myocardial infarction. Am J Cardiol 41: 1127-32.
13. Eaton LW, Weiss JL, Bulkley BH, Garrison JB, Weisfeldt ML. Regional cardiac dilatation after acute myocardial infarction: Recognition by two-dimensional echocardiography. N Engl J Med 1979; 300: 57-62.
14. Erlebacher JA, Weiss JL, Eaton LW, Kallman C, Weisfeldt ML, Bulkley BH. Late effects of acute infarct dilation on heart size: A two dimensional echocardiographic study. Am J Cardiol 1982; 49: 1120-6.
15. Jeremy RW, Allman KC, Bautovitch G, Harris PJ. Patterns of left ventricular dilation during the six months after myocardial infarction. J Am Coll Cardiol 1989; 13: 304-10.
16. Warren SE, Royal HD, Markis JE, Grossman W, McKay RG. Time course of left ventricular dilation after myocardial infarction: influence of infarct-related artery and success of coronary thrombolysis. J Am Coll Cardiol 1988; 11: 12-9.
17. Neskovic AN, Otasevic P, Bojic M, Popovic AD. Association of Killip class on admission and left ventricular dilatation after myocardial infarction: A closer look into an old clinical classification. Am Heart J 1999; 137: 361-7.
18. Gaudron P, Eilles C, Kugler I, Ertl G. Progressive left ventricular dysfunction and remodeling after myocardial infarction. Potential mechanisms and early predictors. Circulation 1993; 87: 755-63.
19. Sjoland H, Herlitz J, Lamm C, Hartford M, Caidahl K. Prediction of left ventricular dysfunction in coronary artery disease from clinical and exercise test findings. Cardiology 1997; 88: 246-53.
20. Risk stratification and survival after myocardial infarction. N Engl J Med 1983; 309: 331-6.
21. Ahnve S, Gilpin E, Henning H, Curtis G, Collins D, Ross Jr J. Limitations and advantages of the ejection fraction for defining high risk after acute myocardial infarction [published erratum appears in Am J Cardiol 1986 Mar 1; 59(6): A12]. Am J Cardiol 1986; 58: 872-8.
22. St John Sutton M, Pfeffer MA, Plappert T et al. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril. Circulation 1994; 89: 68-75.
23. Killip III, T, Kimball JT. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol 1967; 20: 457-64.
24. Norris RM, Brandt PW, Caughey DE, Lee AJ, Scott PJ. A new coronary prognostic index. Lancet 1969; 1: 274-8.
25. Nicolosi GL. Echocardiography to understand remodeling and to assess prognosis after acute myocardial infarction. Int J Cardiol 1998; 65 (Suppl 1): S75-S78.
26. Pfeffer MA, Braunwald E, Moye LA et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE-Investigators. N Engl J Med 1992; 327: 669-77.
27. Rutherford JD, Pfeffer MA, Moye LA et al. Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE Investigators. Circulation 1994; 90: 1731-8.
28. Dwyer Jr, EM, McMaster P, Greenberg H. Nonfatal cardiac events and recurrent infarction in the year after acute myocardial infarction. J Am Coll Cardiol 1984; 4: 695-702.
29. Schuster EH, Bulkley BH. Early post-infarction angina. Ischemia at a distance and ischemia in the infarct zone. N Engl J Med 1981; 305: 1101-5.
30. Schuster EH, Bulkley BH. Ischemia at a distance after acute myocardial infarction: a cause of early postinfarction angina. Circulation 1980; 62: 509-15.